On May 27, 2025, ENDRA Life Sciences Inc. was notified by Nasdaq that it does not meet the minimum stockholders' equity requirement of $2,500,000, as its reported equity is $1,752,885, providing 45 days to submit a compliance plan. The company can be granted up to 180 days to regain compliance but there's no guarantee of success.